Similar articles

• [Gastrointestinal bleeding and ulcerogenic drugs].

  Téri N, Rácz I, Varga L. Téri N, et al. Orv Hetil. 1983 Sep 25;124(39):2363-5. Orv Hetil. 1983. PMID: 6606151 Hungarian. No abstract available.
• [Prevention and treatment of upper gastrointestinal bleeding by nonsteroidal anti-inflammatory drugs].

  Bar-Dayan Y, Levi Y. Bar-Dayan Y, et al. Harefuah. 1996 Apr 15;130(8):535-7. Harefuah. 1996. PMID: 8765878 Review. Hebrew. No abstract available.
• 'Towards assays of gastro-intestinal toxicity of non-steroid anti-inflammatory drugs with improved predictive value in man'.

  Rainsford KD. Rainsford KD. Agents Actions. 1977 Jul;7(2):245-8. doi: 10.1007/BF01969981. Agents Actions. 1977. PMID: 302638 No abstract available.
• Vulnerability of gastric and small intestinal mucosa to ulcerogenic action of indomethacin in C57/BL6/J mice and transient receptor potential channel vanilloid type 1 knockout mice.

  Yarushkina NI, Sudalina MN, Punin YM, Filaretova LP. Yarushkina NI, et al. J Physiol Pharmacol. 2018 Dec;69(6). doi: 10.26402/jpp.2018.6.09. Epub 2019 Feb 21. J Physiol Pharmacol. 2018. PMID: 30802217
• The risk of upper gastrointestinal haemorrhage during steroidal and non-steroidal anti-inflammatory therapy.

  Rooney PJ, Hunt RH. Rooney PJ, et al. Baillieres Clin Rheumatol. 1990 Aug;4(2):207-17. doi: 10.1016/s0950-3579(05)80018-4. Baillieres Clin Rheumatol. 1990. PMID: 2032297 Review. No abstract available.